Article Type
Changed
Fri, 01/11/2019 - 18:23
Display Headline
Phototherapy in the Age of Biologics
Now, phototherapy is an excellent treatment option for many therapeutically challenging dermatologic disorders.

Daniel Walker, BS, and Heidi Jacobe, MD, MSCS

Dermatologists are presented with a diversity of therapeutic modalities for the treatment of inflammatory, sclerosing, and neoplastic conditions, but with the development of various new irradiation devices that utilize specific parts of the electromagnetic spectrum, phototherapy has become a more viable, accessible, and efficacious option in the treatment of these conditions. The ultraviolet (UV) range (10-400 nm) is further subdivided into UVA and UVB, each of which has been particularly useful in a number of skin conditions. The most commonly used forms of UV irradiation are UVA1, psoralen plus UVA (PUVA), and narrowband (NB) UVB. Each of these modalities differ in their mechanism of action, indications, and side effect profiles, and it is important that clinicians be familiar with these differences. Today, phototherapy is a valuable option in the treatment of many nonpsoriatic conditions including atopic dermatitis, sclerosing skin conditions such as morphea, vitiligo, and mycosis fungoides. Due to its relative safety, phototherapy may be used in most populations, including children and pregnant women. However, contraindications and side effects are known and should be considered before patients begin a phototherapeutic regimen.

*For a PDF of the full article, click on the link to the left of this introduction.

Article PDF
Author and Disclosure Information

Publications
Topics
Legacy Keywords
phototherapy, UVA1, narrowband UVB, PUVA, atopic dermatitis, morphea, vitiligo, mycosis fungoides
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF
Now, phototherapy is an excellent treatment option for many therapeutically challenging dermatologic disorders.
Now, phototherapy is an excellent treatment option for many therapeutically challenging dermatologic disorders.

Daniel Walker, BS, and Heidi Jacobe, MD, MSCS

Dermatologists are presented with a diversity of therapeutic modalities for the treatment of inflammatory, sclerosing, and neoplastic conditions, but with the development of various new irradiation devices that utilize specific parts of the electromagnetic spectrum, phototherapy has become a more viable, accessible, and efficacious option in the treatment of these conditions. The ultraviolet (UV) range (10-400 nm) is further subdivided into UVA and UVB, each of which has been particularly useful in a number of skin conditions. The most commonly used forms of UV irradiation are UVA1, psoralen plus UVA (PUVA), and narrowband (NB) UVB. Each of these modalities differ in their mechanism of action, indications, and side effect profiles, and it is important that clinicians be familiar with these differences. Today, phototherapy is a valuable option in the treatment of many nonpsoriatic conditions including atopic dermatitis, sclerosing skin conditions such as morphea, vitiligo, and mycosis fungoides. Due to its relative safety, phototherapy may be used in most populations, including children and pregnant women. However, contraindications and side effects are known and should be considered before patients begin a phototherapeutic regimen.

*For a PDF of the full article, click on the link to the left of this introduction.

Daniel Walker, BS, and Heidi Jacobe, MD, MSCS

Dermatologists are presented with a diversity of therapeutic modalities for the treatment of inflammatory, sclerosing, and neoplastic conditions, but with the development of various new irradiation devices that utilize specific parts of the electromagnetic spectrum, phototherapy has become a more viable, accessible, and efficacious option in the treatment of these conditions. The ultraviolet (UV) range (10-400 nm) is further subdivided into UVA and UVB, each of which has been particularly useful in a number of skin conditions. The most commonly used forms of UV irradiation are UVA1, psoralen plus UVA (PUVA), and narrowband (NB) UVB. Each of these modalities differ in their mechanism of action, indications, and side effect profiles, and it is important that clinicians be familiar with these differences. Today, phototherapy is a valuable option in the treatment of many nonpsoriatic conditions including atopic dermatitis, sclerosing skin conditions such as morphea, vitiligo, and mycosis fungoides. Due to its relative safety, phototherapy may be used in most populations, including children and pregnant women. However, contraindications and side effects are known and should be considered before patients begin a phototherapeutic regimen.

*For a PDF of the full article, click on the link to the left of this introduction.

Publications
Publications
Topics
Article Type
Display Headline
Phototherapy in the Age of Biologics
Display Headline
Phototherapy in the Age of Biologics
Legacy Keywords
phototherapy, UVA1, narrowband UVB, PUVA, atopic dermatitis, morphea, vitiligo, mycosis fungoides
Legacy Keywords
phototherapy, UVA1, narrowband UVB, PUVA, atopic dermatitis, morphea, vitiligo, mycosis fungoides
Article Source

PURLs Copyright

Inside the Article

Article PDF Media